Compound ID | 760
Class: Aminoglycoside
| Agent Type: | Semisynthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive & Gram-negative |
| Mechanism of action: | Protein synthesis inhibitor |
| Description: | Semisynthetic derivative of the natural product verdamicin; Yuan M, Yang XY, Li CR, et al. Susceptibility of Vertilmicin to Modifications by Aminoglycoside Modifying Enzymes. 50th-ICAAC 2010 |
| Institute where first reported: | Inst. of Med.l Biotechnology, China |
| Year first mentioned: | 2010 |
| Highest development stage: | Preclinical |
| Development status: | Experimental |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/101268397 |
| Guide to Pharmacology: | vertilmicin |
| Citation: | https://doi.org/10.1128/aac.00223-09 |